NUVIQ Trademark

Trademark Overview

On Wednesday, May 15, 2013, a trademark application was filed for NUVIQ with the United States Patent and Trademark Office. The USPTO has given the NUVIQ trademark a serial number of 79132559. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, May 14, 2023. This trademark is owned by Octapharma AG. The NUVIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, blood plasma clotting factors, particularly recombinant factor VIII
nuviq

General Information

Serial Number79132559
Word MarkNUVIQ
Filing DateWednesday, May 15, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, May 14, 2023
Registration Number4493134
Registration DateTuesday, March 11, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2013

Trademark Statements

Goods and ServicesPharmaceutical products, namely, blood plasma clotting factors, particularly recombinant factor VIII

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOctapharma AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH-8853 Lachen SZ
CH
Party NameOctapharma AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameOctapharma AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Sunday, December 10, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, December 10, 2023DEATH OF INTERNATIONAL REGISTRATION
Sunday, March 20, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, February 19, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, February 19, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Monday, March 11, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, August 18, 2016NEW REPRESENTATIVE AT IB RECEIVED
Thursday, August 11, 2016NEW REPRESENTATIVE AT IB RECEIVED
Thursday, July 31, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, July 15, 2014FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, July 15, 2014FINAL DISPOSITION PROCESSED
Wednesday, June 11, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 11, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, December 24, 2013NOTIFICATION PROCESSED BY IB
Tuesday, December 24, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2013PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 4, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 4, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 18, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 18, 2013ASSIGNED TO LIE
Tuesday, October 29, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 28, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 28, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 28, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 30, 2013REFUSAL PROCESSED BY IB
Tuesday, September 10, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 10, 2013REFUSAL PROCESSED BY MPU
Tuesday, September 10, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 9, 2013NON-FINAL ACTION WRITTEN
Tuesday, September 3, 2013ASSIGNED TO EXAMINER
Friday, August 23, 2013NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, July 23, 2013APPLICATION FILING RECEIPT MAILED
Friday, July 19, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 18, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

nuviq particularly recombinant factor viii factors clotting products namely blood plasma